Action of PCSK9 inhibitor on LDL receptor

Numéro d’image : 11722833
Action of PCSK9 inhibitor on LDL receptor
Computer illustration showing the action of a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor antibody (green) on the degradation of a low-density lipoprotein molecule (LDL,round) and LDL receptor (LDLR,orange) when bound to a PCSK9 enzyme molecule (blue). When there are high levels of LDL cholesterol in the blood it builds up on the sides of blood vessels hardening them,a condition named atherosclerosis. This narrows the blood vessels and may block them. LDL receptors in cell membranes recognise and bind (upper left) to LDL molecules to remove them from the bloodstream. When PCSK9 binds to an LDLR,the receptor and LDL particle are absorbed by the cell and destroyed (lower left). However,if PCSK9 does not bind,only the LDL particle is destroyed and the receptor can return to the surface of the cell (lower right) and remove more cholesterol. Monoclonal antibodies that bind to and inhibit PCSK9 are being used to reduce the amount of cholesterol in the blood by improving the liver's ability to recycle LDLRs
Licence : Droits gérés
Crédit: Science Photo Library / De Angelis, Maurizio
Taille de l’image : 6000 px × 3750 px
Model Release : Non requis
Property Release : Non requis
Restrictions : -

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;